AKT1 and gastric cancer: Accordingly, a recent study demonstrated that luteolin (20 μmol/L) synergistically inhibited gastric cancer cell proliferation and arrested the cell cycle in the S-phase when combined with the LY294002 inhibitor through inhibition of the PI3K/Akt signaling pathway (Table 2) [98].